Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties

TM Caserta, AN Smith, AD Gultice, MA Reedy… - Apoptosis, 2003 - Springer
TM Caserta, AN Smith, AD Gultice, MA Reedy, TL Brown
Apoptosis, 2003Springer
In recent years, several inhibitors that prevent caspase activation and apoptosis have
emerged. At high doses, however, these inhibitors can have nonspecific effects and/or
become cytotoxic. In this study, we determined the effectiveness of broad spectrum caspase
inhibitors to prevent apoptosis. A carboxy terminal phenoxy group conjugated to the amino
acids valine and aspartate (Q-VD-OPh) potently inhibited apoptosis. Q-VD-OPh was
significantly more effective in preventing apoptosis than the widely used inhibitors, ZVAD …
Abstract
In recent years, several inhibitors that prevent caspase activation and apoptosis have emerged. At high doses, however, these inhibitors can have nonspecific effects and/or become cytotoxic. In this study, we determined the effectiveness of broad spectrum caspase inhibitors to prevent apoptosis. A carboxy terminal phenoxy group conjugated to the amino acids valine and aspartate (Q-VD-OPh) potently inhibited apoptosis. Q-VD-OPh was significantly more effective in preventing apoptosis than the widely used inhibitors, ZVAD-fmk and Boc-D-fmk, and was also equally effective in preventing apoptosis mediated by the three major apoptotic pathways, caspase 9/3, caspase 8/10, and caspase 12. In addition to the increased effectiveness, Q-VD-OPh was not toxic to cells even at extremely high concentrations. Our data indicate that the specificity, effectiveness, and reduced toxicity of caspase inhibitors can be significantly enhanced using carboxyterminal o-phenoxy groups and may have important uses in vivo.
Springer